Ophthotech Corp raised $175,000,000 on , from Clarus Ventures, Hbm Healthcare ....

Get alertedif Ophthotech Corp gets funded!
Amount:$175,000,000
Company:
Investors:, , , ,
Industry:Biotechnology
Country:
State:
City:
United States
New Jersey
Princeton
Key people:Bruce A. Peacock (Chief Business Officer)
Axel Bolte (Board of Directors, Director)
Loni Da Silva (SVP, Global Regulatory Affairs)
Thomas Dyrberg (Board of Director, Director)
Nicholas Galakatos (Board of Director, Director)
David Guyer (Chief Executive Officer, Board of Director, Director)
Evelyn Harrison (Chief Operating Officer, COO, Executive_Officer)
Patricia Johnson (Executive Director, Regulatory CMC, Sr. Director, Regulatory CMC)
Samir Patel (Co-founder and President, Vice Chairman, Board of Directors, Director, Executive_Officer, President & CEO)
Keith Westby (Vice President, Project Management)
Data sources:
www.businesswire.com - Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista™ Anti-PDGF Combination Therapy... http://t.co/WCwIVeyIYs
www.bioportfolio.com - Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista AntiPDGF Combination Therapy in ... http://t.co/XzsMVHzCYt
hcimarket.com - Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista™ Anti-PDGF Combination Therapy... http://t.co/xJXEOEeQ4W
eon.businesswire.com - Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista™ Anti-PDGF Combination Therapy... http://t.co/IEo4vDEA03
www.finsmes.com - Ophthotech Raises $175M in Financing http://t.co/mtuvhReNEj
eyewiretoday.com - Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista Anti-PDGF Combination Therapy i http://t.co/KPE9JDxpIk
www.healio.com - Ophthotech raises $175 million to fund phase 3 trial of wet AMD drug candidate | Ophthalmology
www.privco.com - #Ophthotech Corp raises $50M in #SeriesC #VC from Novo A/S, Clarus, HBM & @SVLifeSciences, part of a $175M financing; http://t.co/UsAjyyA64W
www.4-traders.com - HBM Healthcare Investments AG : Ophthotech secures financing of USD 175 million for phase-III clinical trial of FovistaTM | 4-Traders
www.vcaonline.com - Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista™ Anti-PDGF Combination... http://t.co/aPQu0ssSZ0 | VCA
www.edmontonjournal.com - Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for... http://t.co/IKOfMOHs1K
www.biocentury.com - Ophthotech raises $167.2 million in IPO http://t.co/wisuQc6GQU
world.einnews.com - Ophthotech raises $192.28 million in initial public offering of common stock http://t.co/GP7MRkxd09
Description:
Ophthotech Corp, a Princeton, United States-based company specialized in Biotechnology, closed on a 180M funding round. The funding took place in 2013, May 29th.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!